Biotechnology and the law, Volume 1
This looseleaf treatise is a comprehensive examination of the legal protection available for genetically engineered processes and products in light of the precedent setting Chakrabarty case. Claim formats for protecting bio-engineering techniques and products are included in the work.
What people are saying - Write a review
We haven't found any reviews in the usual places.
activity Amgen amino acid sequence animal antigen Apps argued bacteria Bergy best mode biological material Biotechnology Board Budapest Treaty CCPA cDNA cell line Chakrabarty chemical claimed invention clone coding codon composition compound comprising considered Corp culture deposit disclosed disclosure DNA sequence doctrine of equivalents drug effective enablement encoding enzyme erythropoietin Examiner example Federal Circuit fermentation filing date gene Genentech genetic genus Guidelines held human hybridization hybridoma Hybritech infringement interferon Interfs inventor isolated issue limited manufacture ment method microorganism molecule monoclonal antibody MPEP mutation obtained obvious ordinary skill organism patent application patent protection peptide Plant Patent Plant Patent Act plasmid polypeptide prior art probe proinsulin protein recited recombinant reduction to practice reference rejection rule Scripps SEQ ID Sequence Listing specification strain structure subject matter term tion tissue U.S. Patent USPQ USPQ2d utility utility patent vaccine vector